Patient-derived castration-resistant prostate tumor xenografts show increased GABAergic activation due to phosphorylation and activation of glutamate decarboxylase 65 (GAD65), which synthesizes GABA from glutamate by decarboxylation. Here, GAD2 is linked to prostate neoplasm.